BVF Inc’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176M | Hold |
1,690,221
| – | – | 6.3% | 5 |
|
|
2025
Q1 | $197M | Buy |
1,690,221
+302,157
| +22% | +$35.2M | 8.03% | 2 |
|
|
2024
Q4 | $117M | Buy |
1,388,064
+342,064
| +33% | +$28.9M | 3.98% | 4 |
|
|
2024
Q3 | $94M | Buy |
1,046,000
+91,000
| +10% | +$8.18M | 2.75% | 10 |
|
|
2024
Q2 | $76.9M | Buy |
+955,000
| New | +$76.9M | 2.15% | 14 |
|
|
2024
Q1 | – | Sell |
-1,981,100
| Closed | -$158M | – | 63 |
|
|
2023
Q4 | $158M | Sell |
1,981,100
-150,000
| -7% | -$11.9M | 3.95% | 3 |
|
|
2023
Q3 | $149M | Hold |
2,131,100
| – | – | 4.02% | 3 |
|
|
2023
Q2 | $153M | Hold |
2,131,100
| – | – | 4.27% | 3 |
|
|
2023
Q1 | $131M | Buy |
2,131,100
+376,100
| +21% | +$23.2M | 4.81% | 3 |
|
|
2022
Q4 | $135M | Buy |
+1,755,000
| New | +$135M | 5.71% | 2 |
|